Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1976 1
1977 4
1978 1
1979 1
1980 1
1983 1
1984 2
1985 2
1986 2
1989 3
1990 1
1991 1
1992 3
1993 1
1995 4
1996 2
1997 2
1998 2
1999 2
2000 6
2001 5
2002 4
2003 13
2004 4
2005 9
2006 10
2007 7
2008 7
2009 4
2010 3
2011 4
2012 2
2013 6
2014 10
2015 10
2016 11
2017 17
2018 15
2019 22
2020 16
2021 14
2022 9
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Becker JC, Ugurel S, Leiter U, Meier F, Gutzmer R, Haferkamp S, Zimmer L, Livingstone E, Eigentler TK, Hauschild A, Kiecker F, Hassel JC, Mohr P, Fluck M, Thomas I, Garzarolli M, Grimmelmann I, Drexler K, Spillner AN, Eckhardt S, Schadendorf D; DeCOG. Becker JC, et al. Among authors: fluck m. Lancet. 2023 Sep 2;402(10404):798-808. doi: 10.1016/S0140-6736(23)00769-9. Epub 2023 Jul 11. Lancet. 2023. PMID: 37451295 Clinical Trial.
Robot-assisted assessment of muscle strength.
Toigo M, Flück M, Riener R, Klamroth-Marganska V. Toigo M, et al. Among authors: fluck m. J Neuroeng Rehabil. 2017 Oct 11;14(1):103. doi: 10.1186/s12984-017-0314-2. J Neuroeng Rehabil. 2017. PMID: 29020968 Free PMC article. Review.
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Livingstone E, Zimmer L, Hassel JC, Fluck M, Eigentler TK, Loquai C, Haferkamp S, Gutzmer R, Meier F, Mohr P, Hauschild A, Schilling B, Menzer C, Kiecker F, Dippel E, Roesch A, Ziemer M, Conrad B, Körner S, Windemuth-Kieselbach C, Schwarz L, Garbe C, Becker JC, Schadendorf D; Dermatologic Cooperative Oncology Group. Livingstone E, et al. Among authors: fluck m. Lancet. 2022 Oct 1;400(10358):1117-1129. doi: 10.1016/S0140-6736(22)01654-3. Epub 2022 Sep 10. Lancet. 2022. PMID: 36099927 Clinical Trial.
Gene expression in working skeletal muscle.
Hoppeler H, Klossner S, Flück M. Hoppeler H, et al. Among authors: fluck m. Adv Exp Med Biol. 2007;618:245-54. doi: 10.1007/978-0-387-75434-5_19. Adv Exp Med Biol. 2007. PMID: 18269202 Review.
230 results